Cargando…

Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19

Detalles Bibliográficos
Autores principales:	Klement-Frutos, Elise, Burrel, Sonia, Peytavin, Gilles, Marot, Stéphane, Lê, Minh P., Godefroy, Nagisa, Calvez, Vincent, Marcelin, Anne-Geneviève, Caumes, Eric, Pourcher, Valérie, Boutolleau, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251410/ https://www.ncbi.nlm.nih.gov/pubmed/32473230 http://dx.doi.org/10.1016/j.jinf.2020.05.039

Ejemplares similares

Evolution of viral quasispecies during SARS-CoV-2 infection
por: Jary, Aude, et al.
Publicado: (2020)

Étude COVL : impact de la charge virale nasopharyngée du SARS-COV-2 sur l’évolution clinique en hospitalisation
por: Klement-Frutos, E., et al.
Publicado: (2020)

Corynebacterium striatum thrombophlebitis: a nosocomial multidrug-resistant disease?
por: Tang, Julie, et al.
Publicado: (2021)

Interpretation of SARS-CoV-2 replication according to RT-PCR crossing threshold value
por: Marot, Stéphane, et al.
Publicado: (2021)

Clinical presentation of Covid-19 in health care workers from a French University Hospital
por: Jary, Aude, et al.
Publicado: (2020)

Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19
por: Burrel, Sonia, et al.
Publicado: (2021)

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19
por: Ader, Florence, et al.
Publicado: (2021)

Viral loads in clinical samples of men with monkeypox virus infection: a French case series
por: Palich, Romain, et al.
Publicado: (2023)

Pharmacokinetic interactions between artesunate-mefloquine and ritonavir-boosted lopinavir in healthy Thai adults
por: Rattanapunya, Siwalee, et al.
Publicado: (2015)

Lopinavir/ritonavir monotherapy in clinical practice
por: Caso, A, et al.
Publicado: (2010)

Lopinavir-Ritonavir-Kombination nicht wirksam
por: Diener, Hans-Christoph
Publicado: (2020)

Crushing lopinavir/ritonavir tablets does not result in lower exposure to lopinavir/ritonavir in adult patients with COVID-19
por: Mohsenian Naghani, Shaghayegh, et al.
Publicado: (2023)

Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection
por: Petonnet, Dorian, et al.
Publicado: (2022)

Comparing albuvirtide plus ritonavir-boosted lopinavir regimen to two nucleotide reverse transcriptase inhibitors plus ritonavir-boosted lopinavir in HIV-infected individuals who failed initial treatment: a retrospective comparative cohort study
por: Chen, Liyu, et al.
Publicado: (2022)

Propofol/lopinavir/ritonavir: Bradyarrythmia: case report
Publicado: (2020)

AMBUCOV : description d’un système de dépistage hospitalier en ambulatoire en réponse à l’épidémie de CoViD-19
por: Castandet, L., et al.
Publicado: (2020)

Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with SARS-CoV-2 pneumonia: an opportunistic retrospective analysis
por: Lecronier, Marie, et al.
Publicado: (2020)

Medical features of COVID-19 and influenza infection: A comparative study in Paris, France
por: Faury, Hélène, et al.
Publicado: (2021)

Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers
por: Marot, Stéphane, et al.
Publicado: (2021)

Author Correction: Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers
por: Marot, Stéphane, et al.
Publicado: (2021)

Modulations of human placental transfer of lopinavir, ritonavir and enfuvirtide
por: Ceccaldi, Pierre-François, et al.
Publicado: (2010)

Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients
por: Alvarez, Jean Claude, et al.
Publicado: (2020)

Lopinavir/ritonavir: vomiting and watery diarrhoea: case report
Publicado: (2020)

Risk of bradycardia with lopinavir/ritonavir in COVID-19 patients
Publicado: (2020)

Remdesivir versus ritonavir/lopinavir in COVID-19 patients
por: Vitiello, Antonio, et al.
Publicado: (2020)

The administration of lopinavir/ritonavir via an enteral feeding tube()
por: Sirvent Segovia, Alejandro Esteban, et al.
Publicado: (2021)

Microbiological evaluation of respiratory tract infections in pilgrims returning from countries affected by Middle East respiratory syndrome coronavirus (MERS-CoV)
por: Burrel, S., et al.
Publicado: (2016)

Prolonged replication of BA.1 and BA.2 Omicron lineages compared to Delta variant in nasopharyngeal samples from COVID-19 patients
por: Teyssou, Elisa, et al.
Publicado: (2023)

Comparative efficacy and safety of regimens including ritonavir-boosted lopinavir or nevirapine in antiretroviral-naïve HIV-1-infected individuals
por: Pereira, A, et al.
Publicado: (2010)

Lopinavir/ritonavir in the treatment of HIV-1 infection: a review
por: Chandwani, Ashish, et al.
Publicado: (2008)

Cardio-Metabolic Effects of HIV Protease Inhibitors (Lopinavir/Ritonavir)
por: Reyskens, Kathleen M. S. E., et al.
Publicado: (2013)

Hydroxychloroquine/lopinavir/ritonavir: Exanthema and eosinophilia: 12 case reports
Publicado: (2020)

Maculopapular rash in COVID-19 patient treated with lopinavir/ritonavir
por: Mazan, Paula, et al.
Publicado: (2020)

Immunosuppressants/lopinavir/ritonavir interaction: Various toxicities: case report
Publicado: (2020)

Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19
por: Zhu, Zhen, et al.
Publicado: (2020)

Dexamethasone/hydroxychloroquine/lopinavir/ritonavir: Various toxicities: case report
Publicado: (2021)

Lopinavir/ritonavir/sotalol: Various toxicities: 9 case reports
Publicado: (2021)

Lopinavir/ritonavir delays COVID-19 recovery in paediatric patients
Publicado: (2022)

An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir
por: Laker, Eva Agnes Odongpiny, et al.
Publicado: (2019)

Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study
por: Schneider, L, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_arofppk1o3suhmr9frpiaf04o6